Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced and unlikely to make it to market for several years, industry experts say. Civica, Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials or […]
Ensure the future of local Bay Area News by becoming a Local News Matters member today.
Receive in-depth news stories and arts & entertainment coverage from around the Bay Area in your inbox.
We'll send a verification code to %EMAIL%.
Get the best of Local News Matters directly in your email inbox.
Sending to:
